Narcolepsy Clinical Trials
A listing of Narcolepsy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 25 clinical trials
Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
The purpose of this study is to determine whether FT218 is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.
- 429 views
- 10 Jul, 2018
- 53 locations
Narcolepsy with or without Cataplexy
Do you suffer from excessive daytime sleepiness associated with Narcolepsy?Would you like to try a new investigational drug for Narcolepsy? If you or a loved one suffers from Narcolepsy with or
- 20 views
- 07 Mar, 2022
- 1 location
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations
To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) extended-release capsules (IPX203 ER CD-LD) in comparison to immediate release (IR) CD-LD in the treatment of CD-LD-experienced subjects with Parkinson's disease (PD) who have motor fluctuations.
- 139 views
- 23 Nov, 2020
- 1 location
Novel Drug Treatment for Narcolepsy with Cataplexy
If you or a loved one suffers from Narcolepsy with cataplexy you may qualify for this study! We are currently investigating a drug for the treatment of Narcolepsy that targets the root cause of
- 30 views
- 07 Mar, 2022
- 1 location
Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
The purpose of this study is to determine whether Sodium Oxybate is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.
- 345 views
- 22 Feb, 2019
- 1 location
A Study to Evaluate Safety, and Efficacy of SUVN-G3031 in Patients With Narcolepsy With and Without Cataplexy (SUVN-G3031)
This study is of an investigational drug called SUVN-G3031 as a possible treatment for narcolepsy with cataplexy or narcolepsy without cataplexy. The main purpose of this study is to learn
- 305 views
- 23 Nov, 2020
- 1 location
A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy (SUVN-G3031)
This study is of an investigational drug called SUVN-G3031 (Samelisant) as a possible treatment for narcolepsy with cataplexy or narcolepsy without cataplexy. The main purpose of this study is
- 1734 views
- 07 Oct, 2022
- 41 locations
Constitution of a Clinical, Neurophysiological and Biological Cohort for Chronic Sleep Disorders Responsible of Hypersomnolence (Somnobank)
, hypersomnolence may be primary (central hypersomnia), representing then the most severe form existing in humans. The best-known central hypersomnia is narcolepsy type 1 (NT1), affecting 0.02% of the population
- 188 views
- 11 Feb, 2022
- 1 location
Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia
For diseases that cause excessive daytime sleepiness (such as narcolepsy and idiopathic hypersomnia), there are several medications that can be used to treat sleepiness. However, it can be
- 608 views
- 04 Oct, 2022
- 1 location